Rituximab for the treatment of relapsing steroid sensitive nephrotic syndrome

Document first published:: 20 July 2015
Page updated:: 23 June 2026
Topic:: Specialised commissioning
Publication type:: Policy or strategy

NHS England will commission Rituximab for the treatment of relapsing steroid sensitive nephrotic syndrome in accordance with the criteria outlined in this document.

Document

Rituximab for the treatment of relapsing steroid sensitive nephrotic syndrome

PDF
239 KB
29 pages

Summary

Updated 23 June 2026.

Cookies on the NHS England website

Rituximab for the treatment of relapsing steroid sensitive nephrotic syndrome

Summary